Loading...

FITC Annexin V

Pricing & Availability
Regulatory Status
RUO
Other Names
Annexin A5
Ave. Rating
Submit a Review
Product Citations
publications
AnnexinV_FITC_092908.jpg
Human T leukemia cell line, Jurkat, non-treated (top) or treated (bottom) with BioLegend’s anti-human CD95 (EOS9.1) mAb (cat. 305704) for 6 hours, then stained with Annexin V-FITC and Propidium Iodide (PI) (cat. 421301)
  • AnnexinV_FITC_092908.jpg
    Human T leukemia cell line, Jurkat, non-treated (top) or treated (bottom) with BioLegend’s anti-human CD95 (EOS9.1) mAb (cat. 305704) for 6 hours, then stained with Annexin V-FITC and Propidium Iodide (PI) (cat. 421301)
  • B_AnnexinV_FITC_092908.jpg
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
640905 25 tests $83
Check Availability


Need larger quantities of this item?
Request Bulk Quote
640906 100 tests $194
Check Availability


Need larger quantities of this item?
Request Bulk Quote
640945 300 tests $405
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells. Annexin V Binding Buffer (cat. no. 422201) is recommended for use with Annexin V staining.Annexin V binding alone cannot differentiate between apoptotic cells and necrotic. Therefore, we recommend using our Helix NP™ Blue (Cat. No. 425305), Helix NP™ Green (Cat.  No. 425303) or Helix NP™ NIR (Cat. No. 425301). Early apoptotic cells will exclude 7-AAD and PI, while late stage apoptotic cells and necrotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human, Mouse, Rat
Reported Reactivity
Other Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The purified protein was conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The Annexin V solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per 100,000 - million cells in a 100 µl volume of Annexin V Binding Buffer (Cat No. 422201). It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Annexin V Staining
1. Wash cells twice with cold BioLegend cell staining buffer (Cat. No. 420201) and then resuspend cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 1x106 cells/mL.
2. Transfer 100 µL of cell suspension in 5 ml test tube.
3. Add 5 µL of FITC Annexin V.
4. Add 10 µL of PI solution (Cat. No. 421301) or 7-AAD (Cat. No. 420403/420404).
5. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark.
6. Add 400 µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. Analyze by flow cytometry.


For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.

Application References

(PubMed link indicates BioLegend citation)
  1. Koopman G, et al. 1994. Blood 84:1415.
  2. Vermes I, et al. 1995. J. Immunol. Methods 184:39.
  3. Dachary-Prigent J, et al. 1993. Blood 81:2554.
  4. Sekine C, et al. 2009. Int Immunol. PubMed
  5. Grujic M, et al. 2010. J. Immunol. 185:1730. PubMed
  6. Mulik RS, et al. 2010. Int J Pharm. 398:190. PubMed
  7. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  8. Speth C,et al. 2013. J Infect Dis. 207:823. PubMed
  9. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  10. Gill K, et al. 2013. Biocheim Biophys Acta. 830:2763. PubMed
  11. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  12. Hellmann J, et al. 2013. J. Immunol. 191:1383. PubMed
  13. Sequier S, et al. 2013. PLoS One. 8:70937. PubMed
  14. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  15. Chen YL, et al. 2013. J Exp Med. PubMed
  16. Lin WH, et al. 2014. PLoS One. 9:83160. PubMed
  17. Salge-Bartles U, 2014. Thromb res. 133:244. PubMed
  18. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  19. Intermann J, et al. 2014. Cell Signal. 26:1567. PubMed
  20. de Vires M, 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  21. M Parrula MC, et al. 2014. Virus Res. 189:206. PubMed
  22. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  23. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  24. Awojoodu AO, et al. 2014. Blood. 124:1941. PubMed
  25. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  26. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
Product Citations
  1. Zhang T, et al. 2022. EBioMedicine. 77:103872. PubMed
  2. Dhoonmoon A, et al. 2022. Nat Commun. 13:5063. PubMed
  3. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  4. Derudder E, et al. 2016. Proc Natl Acad Sci U S A. 113: 5065-5070. PubMed
  5. Yao Z, et al. 2018. J Virol. 92:00:00. PubMed
  6. Uriostegui–Arcos M, et al. 2020. Open Biol. 10:200050. PubMed
  7. Dowling CM, et al. 2021. Sci Adv. 7:. PubMed
  8. Lin YN, et al. 2022. Oncoimmunology. 11:2027136. PubMed
  9. Kim EH, et al. 2020. Elife. 9:00. PubMed
  10. Kitayama J, et al. 2016. PLoS One. 11: 0154542. PubMed
  11. Gedye C, et al. 2016. Sci Rep. 6: 25220. PubMed
  12. Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed
  13. Bouhaddou M, et al. 2018. PLoS Comput Biol. 14:e1005985. PubMed
  14. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  15. Lopes-Coelho F, et al. 2021. Front Oncol. 11:656229. PubMed
  16. Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed
  17. Olelewe C, et al. 2022. iScience. 25:104340. PubMed
  18. Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed
  19. Fujii T, et al. 2015. Proc Natl Acad Sci U S A. 112: 12800 - 12805. PubMed
  20. Cardoso B, et al. 2015. PLoS One. 10: 0143897. PubMed
  21. Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed
  22. Figueiredo T, et al. 2020. Mol Psychiatry. . PubMed
  23. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  24. Feng W, et al. 2017. Nat Commun. 0.697916667. PubMed
  25. Jones PD, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1711. PubMed
  26. Kim Y, et al. 2020. J Neurochem. 155:177. PubMed
  27. Hassan MIA, et al. 2021. Comput Struct Biotechnol J. 19:880. PubMed
  28. Ramalingam P, et al. 2020. J Exp Med. 217:00:00. PubMed
  29. Bowen ME, et al. 2019. Dev Cell. 50:212. PubMed
  30. Sales–Dias J, et al. 2019. PLoS One. 14:e0217002. PubMed
  31. Santos LC, et al. 2019. Nat Commun. 1.328472222. PubMed
  32. Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed
  33. Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed
  34. Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed
  35. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  36. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  37. Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed
  38. Macpherson L, et al. 2020. Nature. 577:266. PubMed
  39. Karavasili C, et al. 2017. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2017.05.061. PubMed
  40. Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed
  41. Noguchi F, et al. 2017. Mol Cancer Ther. 1.316666667. PubMed
  42. Kumar S, et al. 2018. Cancers (Basel). 0.724305556. PubMed
  43. Fortin J, et al. 2020. Cancer Cell. 37:308. PubMed
  44. Kim OV, et al. 2022. iScience. 25:104654. PubMed
  45. Shahzadi SK, et al. 2022. Clin Sci (Lond). 136:181. PubMed
  46. Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed
  47. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  48. Pfalzgraff A, et al. 2016. Sci Rep. 6:31577. PubMed
  49. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  50. Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
  51. Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed
  52. Chen MS, et al. 2019. Mol Cancer Res. 17:697. PubMed
  53. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  54. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  55. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  56. Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed
  57. Wang M, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.097. PubMed
  58. Beeravolu N, McKee C, Chaudhry G 2017. J App Toxicol. 10.1002/jat.3469. PubMed
  59. Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed
  60. O'Connor MJ, et al. 2021. Oncogene. 40:4872. PubMed
  61. Parrula M, et al. 2014. Virus Res. 189:206. PubMed
  62. Brigger D, et al. 2015. Cell Death Dis. 6: e1861. PubMed
  63. Zhang J, et al. 2016. Cell Death Dis. 7:e2266. PubMed
  64. Wang D, et al. 2016. J Cell Sci. 129: 2261 - 2272. PubMed
  65. Uchtenhagen H, et al. 2016. Nat Commun. 7:12614. PubMed
  66. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  67. Esteghamat F, et al. 2019. Nat Genet. 51:1233. PubMed
  68. Blümel E, et al. 2020. Oncoimmunology. 9:1751561. PubMed
  69. Sekine C, et al. 2009. Int Immunol. 1.079861111. PubMed
  70. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  71. Martín Monreal MT, et al. 2021. Front Immunol. 12:716250. PubMed
  72. Schmitz RL, et al. 2021. Cells. 10:. PubMed
  73. Babaei A, et al. 2021. Adv Pharm Bull. 11:361. PubMed
  74. Madala HR, et al. 2020. Cancer Res. 3492:80. PubMed
  75. Clements KE, et al. 2020. Nat Commun. 4.706944444. PubMed
  76. Rauzan M, et al. 2017. PLoS One. 12:e0174107. PubMed
  77. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  78. Chiani M, et al. 2017. Artif Cells Nanomed Biotechnol. 10.1080/21691401.2017.1337029. PubMed
  79. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  80. Norkin M, et al. 2021. Cell Rep. 35:109026. PubMed
  81. Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed
  82. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  83. Khatib JB, et al. 2022. Oncotarget. 13:1078. PubMed
  84. Salge-Bartels U, et al. 2014. Thromb Res. 133:244. PubMed
  85. Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed
  86. Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed
  87. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  88. Herold N, et al. 2017. Nat Med. 23:256-263. PubMed
  89. Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed
  90. Müller I, et al. 2020. Mol Cell. 970:77. PubMed
  91. Kamiyama N, et al. 2017. Antiviral Res. 10.1016/j.antiviral.2017.08.007. PubMed
  92. Montero–Herradón S, et al. 2017. Organogenesis. 0.675. PubMed
  93. Nunes SC, et al. 2018. Sci Rep. 6.939583333. PubMed
  94. Sharif T, et al. 2018. Autophagy. 1.101388889. PubMed
  95. Eichelmann AK, et al. 2018. Sci Rep. 8:17553. PubMed
  96. Blümel E, et al. 2019. Oncoimmunology. 8:e1641387. PubMed
  97. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  98. Vanoli F, et al. 2021. Oncogene. 40:5095. PubMed
  99. Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed
  100. Smith CM, et al. 2021. Biochem J. 478:3331. PubMed
  101. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  102. Meyer N, et al. 2021. J Clin Med. 10:. PubMed
  103. Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed
  104. Chheda Z, et al. 2016. J Immunol. 197: 2016 - 2026. PubMed
  105. Slone E, et al. 2015. J Leukoc Biol. 98: 791 - 804. PubMed
  106. Séguier S, et al. 2013. PLoS One. 8:70937. PubMed
  107. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  108. Zervou S, et al. 2017. PLoS One.. 10.1371/journal.pone.0182994. PubMed
  109. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  110. Gholamrezaei M, et al. 2021. Iran J Parasitol. 15:475. PubMed
  111. Meyer N, et al. 2021. Int J Mol Sci. 22:. PubMed
  112. Kolbrink B, et al. 2022. Cell Mol Life Sci. 79:387. PubMed
  113. Wang Q, et al. 2013. Genes Dev. 27:615. PubMed
  114. Douguet L, et al. 2016. PLoS One. 11:e0166164. PubMed
  115. Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed
  116. Pajarillo E, et al. 2020. J Biol Chem. 295:3040. PubMed
  117. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  118. Rajavel T, et al. 2017. Sci Rep. 2.665277778. PubMed
  119. Grujic M, et al. 2010. J Immunol. 185:1730. PubMed
  120. Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed
  121. Lee DH, et al. 2020. Circ Res. 127:1182. PubMed
  122. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  123. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  124. Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed
  125. Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed
  126. Polak R, et al. 2015. Blood. 126: 2404 - 2414. PubMed
  127. Matsumoto A, et al. 2019. J Extracell Vesicles. 9:1696517. PubMed
  128. Pirali T, et al. 2017. ChemMedChem. 1.570833333. PubMed
  129. Nastasi C, et al. 2021. Sci Rep. 11:1458. PubMed
  130. Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  131. Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed
  132. Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed
  133. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  134. Dhoonmoon A, et al. 2020. Nucleic Acids Res. 48:7252. PubMed
  135. Hafez A, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.46. PubMed
  136. Putheti P, et al. 2010. PLoS One. 5:e8706. PubMed
  137. Shadboorestan A, et al. 2022. Iran J Basic Med Sci. 25:506. PubMed
  138. Huang Y, et al. 2022. Front Cell Dev Biol. 9:837777. PubMed
  139. Babaei A, et al. 2020. Daru. 28:555. PubMed
  140. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  141. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  142. Liu B, et al. 2016. J Biol Chem. 291: 23869 - 23881. PubMed
  143. Lhuillier C, et al. 2015. J Biol Chem. 290: 16797 - 16811. PubMed
  144. Passaro C, et al. 2013. Endocr Relat Cancer. 20:633. PubMed
  145. Mulik R, et al. 2010. Int J Pharm. 398:190. PubMed
  146. Speth C, et al. 2013. J Infect Dis. 207:823. PubMed
  147. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  148. Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed
  149. Ki H, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.09.118. PubMed
  150. Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed
  151. Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed
  152. Jackson LM, et al. 2021. Nucleic Acids Res. 49:12855. PubMed
  153. Lin W, et al. 2014. PLoS One. 9:83160. PubMed
  154. Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed
  155. CO L, et al. 2015. Nat Commun. 6: 7739. PubMed
  156. Huang YL, et al. 2020. Elife. 9:00. PubMed
  157. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  158. Di Somma S, et al. 2019. Cancers (Basel). 1.70625. PubMed
  159. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  160. Alcon C, et al. 2021. Cells. 10:. PubMed
  161. Cao H, et al. 2021. Nat Commun. 12:1792. PubMed
  162. Faria M, et al. 2017. PLoS One. 12(2):e0172689. PubMed
  163. Jones P, et al. 2016. J Biol Chem. 291: 16318 - 16327. PubMed
  164. Awojoodu A, et al. 2014. Blood. 124:1941. PubMed
  165. Intemann J, et al. 2014. Cell Signal. 26:1567. PubMed
  166. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  167. Fang P, et al. 2019. Commun Biol. 0.315972222. PubMed
  168. Kumar S, et al. 2019. Int J Cancer. 146:1652. PubMed
  169. Zhao CC, et al. 2018. Oncol Rep. 40:3392. PubMed
  170. Schleicher EM, et al. 2018. Nucleic Acids Res. 46:8908. PubMed
  171. Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed
  172. Bostanabad SY, et al. 2021. Sci Rep. 11:1539. PubMed
  173. Monzen S, et al. 2022. Mol Clin Oncol. 16:19. PubMed
  174. Konda P, et al. 2022. Am J Cancer Res. 12:210. PubMed
  175. Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed
  176. Clements KE, et al. 2018. Nucleic Acids Res. 46:8898. PubMed
  177. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  178. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  179. Paparella AS, et al. 2021. Nat Commun. 12:6285. PubMed
  180. Huang YL, et al. 2021. iScience. 24:103168. PubMed
  181. Zhang Y, et al. 2021. Cell Death Dis. 0.563194444. PubMed
  182. Kang JH, et al. 2020. Cell Death Dis. 0.803472222. PubMed
  183. Dewdney B, et al. 2020. Sci Rep. 10:16769. PubMed
  184. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  185. Coutaz M, et al. 2016. Sci Rep. 6:39117. PubMed
  186. Akane K, et al. 2016. Proc Natl Acad Sci U S A. 113: 2460 - 2465. PubMed
  187. Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed
  188. Chen Y, et al. 2013. J Exp Med. 210:2515. PubMed
  189. Mendès C, et al. 2019. Sci Rep. 9:14107. PubMed
  190. Lopes–Coelho F, et al. 2017. Oncotarget. 8:82803. PubMed
  191. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  192. Thanuthanakhun N, et al. 2017. PLoS One. . 10.1371/journal.pone.0187610. PubMed
  193. Kuntz E, et al. 2017. Nat Med. 10.1038/nm.4399. PubMed
  194. Kasikara C, et al. 2021. J Clin Invest. 131:. PubMed
  195. Ning N, et al. 2022. Theranostics. 12:5537. PubMed
  196. Bottardi S, et al. 2020. Exp Hematol. 68:88. PubMed
  197. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  198. He J, et al. 2017. FASEB J. 31:2893. PubMed
  199. Lyu X, et al. 2019. BMC Genomics. 1.235416667. PubMed
  200. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  201. Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed
  202. Wang Y, et al. 2022. Front Cardiovasc Med. 9:876087. PubMed
  203. Shankman LS, et al. 2021. Curr Biol. 31:2469. PubMed
  204. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  205. Pahari S, et al. 2020. Autophagy. 1.375694444. PubMed
  206. Schleicher EM, et al. 2020. PLoS Genet. 16:e1009176. PubMed
  207. Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed
  208. Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed
  209. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  210. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  211. Gill K, et al. 2013. Biochim Biophys Acta. 1830:2763. PubMed
  212. Young MM, et al. 2019. Cell Death Dis. 1.004861111. PubMed
  213. Santos I, et al. 2019. Nutrients. 2.210416667. PubMed
  214. Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed
  215. Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed
  216. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
RRID
AB_2561291 (BioLegend Cat. No. 640905)
AB_2561292 (BioLegend Cat. No. 640906)
AB_2629519 (BioLegend Cat. No. 640945)

Antigen Details

Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID
308 View all products for this Gene ID
UniProt
View information about Annexin V on UniProt.org

Related FAQs

How is your Annexin made and what sequence does it cover?

It is made in E. coli, covering human aa Met1-Asp320.

How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?

Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.

Why do I need to use Annexin V Binding Buffer?

Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.

Can I use RPMI during Annexin V staining?

It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.

Can I freeze Annexin V conjugates?

It should not be frozen as it will lead to loss of biological activity due to dimerization.

Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?

Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.

Go To Top Version: 6    Revision Date: 11/01/2023

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account